Santo R. Mercuri
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 148 publications
Predictors of outcomes and satisfaction with tirbanibulin in actinic keratosis: a multicenter real-world study.
Journal: Italian journal of dermatology and venereology
Published: August 24, 2026
Real-World Effectiveness and Safety of Bimekizumab for Moderate-to-Severe Hidradenitis Suppurativa: A Multicenter Retrospective Study from the Italian Landscape HS (IL-HS).
Journal: Dermatology and therapy
Published: July 14, 2026
Intradermal tranexamic acid and melasma: a systematic review and level of evidence.
Journal: Italian journal of dermatology and venereology
Published: May 21, 2026
Real-world effectiveness of topical ruxolitinib in non-segmental vitiligo: repigmentation, mental health, and quality-of-life outcomes in an 860-patient multicentre study.
Journal: The British journal of dermatology
Published: May 16, 2026
Longitudinal Response Trajectories with Dupilumab or Upadacitinib in Moderate-to-Severe Atopic Dermatitis: A Multicentre Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis).
Journal: Dermatology and therapy
Published: March 17, 2026
Widespread dermoscopic alterations of multiple melanocytic nevi in a patient receiving vandetanib: implications for dermatological surveillance.
Journal: Dermatology reports
Published: March 01, 2026
Lebrikizumab After Multiple Prior Advanced Therapies in Moderate-To-Severe Atopic Dermatitis: A Real-World Case Series.
Journal: International journal of dermatology
Published: January 02, 2026
Short-Term Effectiveness and Safety of Deucravacitinib in Psoriasis: A Multicenter Real-World Study with Scalp-Specific Outcomes-IL PSO (Italian Landscape Psoriasis).
Journal: Dermatology and therapy
Published: December 26, 2025
Tildrakizumab in Managing Psoriasis with Involvement of Difficult-to-Treat Areas: A Multicenter Real-Life Retrospective Study.
Journal: Journal of clinical medicine
Published: December 21, 2025
Ectoparasite- and Vector-Borne-Related Dermatoses: A Single-Centre Study with Practical Diagnostic and Management Insights in a One Health Perspective.
Journal: Journal of clinical medicine
Published: November 30, 2025
Successful use of upadacitinib for the improvement of vitiligo-like and perifollicular dyspigmentation (salt-and-pepper skin) in systemic sclerosis.
Journal: Dermatology reports
Published: October 16, 2025
Long-Term Treatment With Systemic Rifampicin and Clindamycin for Epidermal Growth Factor Receptor Inhibitor-Related Acneiform and Mucocutaneous Rash: A Valid Therapeutic Option.
Journal: International journal of dermatology
Published: September 30, 2025
Last Updated: 09/26/2026